Jones, M.; Wang, J.; Harmon, S.; Kling, B.; Heilmann, J.; Gilmer, J.F.
Novel Selective Butyrylcholinesterase Inhibitors Incorporating Antioxidant Functionalities as Potential Bimodal Therapeutics for Alzheimer’s Disease. Molecules 2016, 21, 440.
https://doi.org/10.3390/molecules21040440
AMA Style
Jones M, Wang J, Harmon S, Kling B, Heilmann J, Gilmer JF.
Novel Selective Butyrylcholinesterase Inhibitors Incorporating Antioxidant Functionalities as Potential Bimodal Therapeutics for Alzheimer’s Disease. Molecules. 2016; 21(4):440.
https://doi.org/10.3390/molecules21040440
Chicago/Turabian Style
Jones, Mike, Jun Wang, Shona Harmon, Beata Kling, Jörg Heilmann, and John F. Gilmer.
2016. "Novel Selective Butyrylcholinesterase Inhibitors Incorporating Antioxidant Functionalities as Potential Bimodal Therapeutics for Alzheimer’s Disease" Molecules 21, no. 4: 440.
https://doi.org/10.3390/molecules21040440
APA Style
Jones, M., Wang, J., Harmon, S., Kling, B., Heilmann, J., & Gilmer, J. F.
(2016). Novel Selective Butyrylcholinesterase Inhibitors Incorporating Antioxidant Functionalities as Potential Bimodal Therapeutics for Alzheimer’s Disease. Molecules, 21(4), 440.
https://doi.org/10.3390/molecules21040440